Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
MELBOURNE,Australia and INDIANAPOLIS,Ind.,Feb. 20,2025--Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq:TLX,Telix,the Company) today announces its financial results for the year ended 31 December 2024